🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UBS upgrades Hannover Re stock to 'Neutral' amid resilience

EditorEmilio Ghigini
Published 2024/06/03, 10:28
HNRGn
-

On Monday, UBS adjusted its stance on Hannover Rueck SE (OTC:HVRRY) (HNR1:GR) (OTC: HVRRF), upgrading the stock from Sell to Neutral and increasing the price target to €234 from €219.

The revision reflects the firm's assessment that Hannover Re is well-positioned to navigate the upcoming active catastrophe season effectively.

Additionally, UBS anticipates that the company's already resilient liability reserves could see a further increase of approximately 10% in 2024.

The reassessment by UBS also takes into account the potential impact of upcoming Standard & Poor's model changes, which could indicate a more favorable capital distribution policy. These changes are expected to be announced with the company's second-quarter results.

Furthermore, UBS noted that Hannover Re's year-to-date performance has been underwhelming, with the stock now trading at a price-to-earnings ratio that aligns with its five-year average relative to the SXIP index.

UBS's decision to upgrade Hannover Re to Neutral is driven by a combination of factors, including earnings per share revisions and an analysis of the company's reserve prudence. The firm believes that the risks associated with the stock are now more balanced, which justifies the revised price target and rating.

The upgrade and new price target come at a time when investors are closely monitoring the insurance sector, particularly as it prepares for what is anticipated to be an active season for natural catastrophes.

Hannover Re's potential to strengthen its reserves further and the possibility of a positive shift in capital distribution strategy are key elements that influenced UBS's updated outlook on the stock.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.